Science spotlight: Doudna lab’s cell-penetrating CRISPR RNPs, durable epigenome editing and more
BioCentury’s roundup of translational innovations
A peptide-based strategy for enhancing cellular uptake of a non-viral CRISPR system could enable in vivo use of more precise and less immunogenic genome editors.
CRISPR ribonucleoprotein (RNP) genome editors’ advantages over virally delivered CRISPR machinery include reduced off-target and immunogenic effects. The RNP carries the Cas protein and guide RNA directly, without relying on a delivery vector, but its ability to enter cells is limited. ...
BCIQ Company Profiles
San Raffaele Telethon Institute for Gene Therapy